SI-Bone Inc (NASDAQ:SIBN) Chairman Jeffrey W. Dunn sold 40,000 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $19.64, for a total transaction of $785,600.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
NASDAQ SIBN opened at $20.03 on Thursday. The company has a fifty day simple moving average of $19.13 and a two-hundred day simple moving average of $18.14. The stock has a market cap of $480.46 million and a P/E ratio of -28.21. SI-Bone Inc has a 12-month low of $14.08 and a 12-month high of $23.03. The company has a current ratio of 12.00, a quick ratio of 11.55 and a debt-to-equity ratio of 0.50.
SI-Bone (NASDAQ:SIBN) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.40) by $0.05. The business had revenue of $16.32 million during the quarter. SI-Bone had a negative net margin of 46.59% and a negative return on equity of 84.84%. As a group, sell-side analysts forecast that SI-Bone Inc will post -1.4 earnings per share for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of SIBN. First Light Asset Management LLC purchased a new position in shares of SI-Bone in the second quarter worth $13,248,000. BlackRock Inc. raised its holdings in shares of SI-Bone by 70.7% in the second quarter. BlackRock Inc. now owns 1,120,294 shares of the company’s stock worth $22,787,000 after buying an additional 463,874 shares during the last quarter. Meridian Investment Counsel Inc. purchased a new position in shares of SI-Bone in the second quarter worth $7,813,000. Capital Bank & Trust Co purchased a new position in shares of SI-Bone in the second quarter worth $5,249,000. Finally, Vanguard Group Inc. raised its holdings in shares of SI-Bone by 65.5% in the second quarter. Vanguard Group Inc. now owns 563,111 shares of the company’s stock worth $11,454,000 after buying an additional 222,788 shares during the last quarter. 42.86% of the stock is owned by institutional investors and hedge funds.
SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Further Reading: What are popular green investing opportunities?
Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.